Edition:
United Kingdom

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,524JPY
6:00am GMT
Change (% chg)

¥38 (+2.52%)
Prev Close
¥1,486
Open
¥1,502
Day's High
¥1,526
Day's Low
¥1,492
Volume
6,766,200
Avg. Vol
7,646,062
52-wk High
¥1,570
52-wk Low
¥1,332

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 359,689.00 29.970
Sep 317,183.00 19.370
Jun 322,571.00 20.543
FY 2017 Mar '17 306,078.00 19.162
Dec 353,914.00 30.200
Sep 313,921.00 22.773
Jun 337,752.00 31.308
FY 2016 Mar '16 307,040.00 13.651
Dec 378,165.00 28.632
Sep 343,842.00 26.919
Jun 343,659.00 20.352
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 321,500.00 321,500.00 321,500.00 --
Quarter Ending Sep-18 1 329,800.00 329,800.00 329,800.00 --
Year Ending Mar-18 11 1,295,180.00 1,332,340.00 1,254,000.00 1,386,890.00
Year Ending Mar-19 11 1,292,660.00 1,329,000.00 1,252,000.00 1,406,440.00
Earnings (per share)
Quarter Ending Jun-18 1 26.92 26.92 26.92 --
Quarter Ending Sep-18 1 31.35 31.35 31.35 --
Year Ending Mar-18 12 91.12 105.07 77.25 101.73
Year Ending Mar-19 12 96.22 106.45 80.07 103.85
LT Growth Rate (%) 2 -3.58 -1.40 -5.77 3.92
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.71 31.10 32.90
P/E High - Last 5 Yrs. 32.04 40.92 45.97
P/E Low - Last 5 Yrs. 14.16 23.79 24.37
Beta 0.60 0.90 0.89
Price to Sales (TTM) 2.32 3.98 5.77
Price to Book (MRQ) 2.28 4.84 5.41
Price to Tangible Book (MRQ) 4.42 5.66 6.98
Price to Cash Flow (TTM) 11.66 23.02 23.42
% Owned Institutions -- 1.25 2.22

Dividends

  Company industry sector
Dividend Yield 2.34 1.57 1.50
Dividend Yield - 5 Year Avg 2.08 1.58 1.52
Dividend 5 Year Growth Rate 6.34 4.33 5.21
Payout Ratio(TTM) 36.62 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -4.49 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -5.14 4.72 5.59
Sales - 5 Yr. Growth Rate 6.23 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.38 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago -7.79 -- --
EPS - 5 Yr. Growth Rate 25.07 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -5.38 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.76 2.11 2.18
Current Ratio (MRQ) 2.18 2.89 2.97
LT Debt to Equity (MRQ) 2.56 9.91 12.22
Total Debt to Equity (MRQ) 2.86 13.93 16.52
Interest Coverage (TTM) -- 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 74.68 55.11 54.70
Gross Margin - 5 Yr. Avg. 73.10 52.40 52.42
EBITD Margin (TTM) 21.37 -- --
EBITD - 5 Yr. Avg 23.24 18.51 10.86
Operating Margin (TTM) 16.31 14.36 4.64
Operating Margin - 5 Yr. Avg. 15.33 14.42 6.26
Pre-Tax Margin (TTM) 18.28 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. 16.23 14.73 6.60
Net Profit Margin (TTM) 15.01 11.05 1.76
Net Profit Margin - 5 Yr. Avg. 12.09 11.07 2.91
Effective Tax Rate (TTM) 17.93 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. 25.52 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 75,368,224 948,737,542 855,667,832
Net Income/Employee (TTM) 11,310,080 111,622,076 100,655,557
Receivable Turnover (TTM) 3.85 5.62 5.78
Inventory Turnover (TTM) 2.01 2.58 3.35
Asset Turnover (TTM) 0.72 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.82 11.45 10.98
Return on Assets - 5 Yr. Avg. 8.69 12.98 12.37
Return on Investment (TTM) 13.91 14.90 14.43
Return on Investment - 5 Yr. Avg. 11.14 16.98 16.18
Return on Equity (TTM) 15.50 16.41 16.13
Return on Equity - 5 Yr. Avg. 11.87 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -4.45 4.79 6.23
EPS (TTM) % 15.55 36.87 25.07
Dividend % 6.25 7.99 6.34
Note: Units in Millions of US Dollars

Performance for Astellas Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.32 0.42 99 25
13 Week 5.55 0.53 99 35
26 Week -2.54 -13.95 99 30
52 Week -8.08 -26.24 99 12
YTD -10.32 -19.28 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.51%
# of Holders: 445
Total Shares Held: 1,148,357,658
3 Mo. Net Change: -12,751,212
# New Positions: 6
# Closed Positions: 6
# Increased Positions: 98
# Reduced Positions: 98
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.